DECODING LONG COVID: A BIOCHEMICAL PERSPECTIVE 🧠

🧬 In the ever-evolving landscape of post-pandemic health, a new opinion article by Dr. Carla P. Rus in Frontiers in Neurology (2025) offers a compelling dive into the biochemical roots of Long COVID, or Post-COVID Syndrome (PCS). Drawing from neuropsychiatry and biochemistry, the article explores how serotonin depletion and kynurenine pathway disruption could underlie the lingering symptoms so many continue to face.

         🔹  At the heart of the discussion lies tryptophan; a vital amino acid that fuels both serotonin and kynurenine production. The paper suggests that malabsorption of tryptophan, heightened monoamine oxidase (MAO) activity, and gut-brain axis alterations may explain why patients with PCS experience brain fog, fatigue, anxiety, and dysautonomia.
          🔹  Dr. Carla P. Rus proposes that these insights aren't just theoretical; they open the door for biomarker discovery and targeted treatments that could finally bring relief to millions grappling with Long COVID’s shadow.
          🔹 This essay-style contribution stands as a call to the medical community: dig deeper, think broader, and connect the dots between biochemistry, immunity, and neuropsychiatric health.

🔗 Read it here: https://lnkd.in/dxK_cjKc

#LongCOVID #Neuroscience #Biochemistry #Tryptophan #Serotonin #KynureninePathway #Neuroinflammation #PostCovidSyndrome #MentalHealth #FrontiersInNeurology #ScienceForHealth #BrainFog #COVID19Recovery #MAO #GutBrainAxis #ResearchMatters #InnovationInMedicine

Popular posts from this blog

CHROMOSOMAL MICROARRAY VS. WHOLE EXOME SEQUENCING

Image
“𝓜𝓲𝓬𝓻𝓸𝓪𝓻𝓻𝓪𝔂𝓼 𝓱𝓮𝓵𝓹 𝓾𝓼 𝓯𝓲𝓷𝓭 𝓶𝓲𝓼𝓼𝓲𝓷𝓰 𝓸𝓻 𝓮𝔁𝓽𝓻𝓪 𝓬𝓱𝓻𝓸𝓶𝓸𝓼𝓸𝓶𝓪𝓵 𝓹𝓲𝓮𝓬𝓮𝓼; 𝓦𝓔𝓢 𝓽𝓪𝓴𝓮𝓼 𝓾𝓼 𝓭𝓮𝓮𝓹𝓮𝓻, 𝓲𝓷𝓽𝓸 𝓽𝓱𝓮 𝓬𝓸𝓭𝓲𝓷𝓰 𝓻𝓮𝓰𝓲𝓸𝓷𝓼 𝔀𝓱𝓮𝓻𝓮 𝓻𝓪𝓻𝓮 𝓿𝓪𝓻𝓲𝓪𝓷𝓽𝓼 𝓱𝓲𝓭𝓮.” — Ellen Matloff 🧬 Chromosomal Microarray (CMA) and Whole Exome Sequencing (WES) are cornerstones of modern genomic diagnostics. Each offers unique insights: CMA identifies large-scale structural changes like copy number variations (CNVs), while WES investigates the exome; the protein-coding portion where most pathogenic mutations reside. 🔹 CMA is a first-line tool for neurodevelopmental disorders, intellectual disability, and congenital anomalies. It scans for chromosomal imbalances missed by karyotyping, offering ~15–20% diagnostic yield in such cases. Its speed and cost-effectiveness make it a go-to for initial evaluations. 🔹 WES, by contrast, dives into the exonic 1–2% of the genome that harbors ~85% of known disease-causing ...
Read more